Gerresheimer AGXSWX:GXI +0.24%73 PE Ratio (TTM) is 39.59 as of Jul. 02, 2026, which is 61% above its 10-year median of 24.65. GuruFocus rates XSWX:GXI with a GF Score™ of 73/100 and a GF Value™ of CHF87.96 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 435 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 69.66% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-02), Gerresheimer AG's share price is
CHF25.02.
Gerresheimer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63. Therefore, Gerresheimer AG's PE Ratio (TTM) for today is 39.59.
The historical rank and industry rank for Gerresheimer AG's PE Ratio (TTM) or its related term are showing as below:
XSWX:GXI'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 9.61 Med: 24.65 Max: 65.59
Current: 41.18
During the past 13 years, the highest PE Ratio (TTM) of Gerresheimer AG was 65.59. The lowest was 9.61. And the median was 24.65.
XSWX:GXI's PE Ratio (TTM) is ranked worse than 69.66% of 435
companies
in the Medical Devices & Instruments industry
Industry Median: 26.03
vs XSWX:GXI: 41.18
During the past 12 months, Gerresheimer AG's average EPS without NRIGrowth Rate was -79.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 3.40% per year.
During the past 13 years, Gerresheimer AG's highest 3-Year average EPS without NRI Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.60% per year.
Gerresheimer AG's EPS (Basic) for the
three
months ended in Aug. 2025 was CHF-0.35.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63.
Gerresheimer AG (XSWX:GXI) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Gerresheimer AG PE Ratio (TTM) Related Terms
Gerresheimer AG PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GXI vs ISRG, BDX, MDLN: PE Ratio (TTM) Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Gerresheimer AG's Share Price of today is CHF25.02.
Gerresheimer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.63.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Gerresheimer AG (XSWX:GXI) has a PE Ratio (TTM) of 39.59 as of Jul. 02, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Gerresheimer AG and its competitors. This is 61% above median its historical median of 24.65. Over the past decade, Gerresheimer AG's PE Ratio (TTM) has ranged from 9.61 to 65.59. According to the industry distribution chart, Gerresheimer AG ranks #303 out of 435 companies in the Medical Devices & Instruments industry, placing it in the top 69.7%.
Is Gerresheimer AG's PE Ratio (TTM) too high?
Gerresheimer AG's current PE Ratio (TTM) of 39.59 is 61% above median its 10-year median of 24.65. Over the past 10 years, this metric has ranged from a low of 9.61 to a high of 65.59. The Medical Devices & Instruments industry median PE Ratio (TTM) is 26.03. Gerresheimer AG's value of 39.59 is 52.1% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #303 out of 435 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's PE Ratio (TTM) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #303 out of 435 companies for PE Ratio (TTM). This places Gerresheimer AG in the lower half of its industry. The industry median PE Ratio (TTM) is 26.03. Gerresheimer AG's value of 39.59 is 52.1% above this benchmark. Historically, Gerresheimer AG's own PE Ratio (TTM) has ranged from 9.61 to 65.59 over the past decade. While the company's 10-year median is 24.65 vs. the industry median of 26.03, Gerresheimer AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 26.03, based on 435 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current PE Ratio (TTM) of 39.59 is 52.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 26.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current PE Ratio (TTM) is 39.59, which is 61% above median its own 10-year median of 24.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current PE Ratio (TTM) is 39.59, which is 61% above median its 10-year median of 24.65 and 52.1% above the Medical Devices & Instruments industry median of 26.03. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current PE Ratio (TTM) is 39.59 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for XSWX:GXI:
PE Ratio (TTM): 39.59 (61% above median its 10-year median of 24.65)
GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
Industry Position: 52.1% above the Medical Devices & Instruments median (#303 of 435)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score
Get the complete analysis for XSWX:GXI
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
